| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R44ES036385 | An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effects | 000 | 1 | NIH | 1/27/2025 | $0 |
| | 2025 | 2023 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R43TR004743 | The Pain in a Dish Assay (PIDA): a high throughput system featuring human stem cell-derived nociceptors and dorsal horn neurons to test compounds for analgesic activity | 000 | 1 | NIH | 12/13/2024 | $0 |
| | 2025 | 2023 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R44MH135526 | Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs) | 000 | 1 | NIH | 3/13/2025 | $0 |
| | 2025 | 2022 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R44MH119621 | The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND) | 000 | 3 | NIH | 10/9/2024 | $0 |
| | 2025 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 000 | 1 | NIH | 3/14/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,764,039 ) |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 006 | 3 | NIH | 8/15/2024 | $152,796 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 001 | 2 | NIH | 6/12/2024 | $16,853 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 002 | 2 | NIH | 6/27/2024 | $9,527 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 005 | 3 | NIH | 8/12/2024 | $13,554 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 004 | 3 | NIH | 8/9/2024 | $174,007 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 000 | 2 | NIH | 1/22/2024 | $120,499 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R44ES036385 | An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effects | 000 | 1 | NIH | 6/20/2024 | $1,217,093 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R44MH135526 | Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs) | 000 | 2 | NIH | 8/28/2024 | $1,139,473 |
| | 2024 | 2024 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-3212 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 003 | 3 | NIH | 8/7/2024 | $920,237 |
|
| Issue Date FY: 2023 ( Subtotal = $1,972,609 ) |
| | 2023 | 2023 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 001 | 2 | NIH | 8/3/2023 | $1,056,800 |
| | 2023 | 2023 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43TR004743 | The Pain in a Dish Assay (PIDA): a high throughput system featuring human stem cell-derived nociceptors and dorsal horn neurons to test compounds for analgesic activity | 000 | 1 | NIH | 9/1/2023 | $350,064 |
| | 2023 | 2023 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44MH135526 | Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs) | 000 | 1 | NIH | 9/1/2023 | $565,745 |
| | 2023 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 000 | 1 | NIH | 3/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $940,992 ) |
| | 2022 | 2022 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44MH119621 | The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND) | 001 | 3 | NIH | 4/8/2022 | $940,992 |
| | 2022 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 000 | 1 | NIH | 8/22/2022 | $0 |
| | 2022 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44MH119621 | The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND) | 000 | 2 | NIH | 11/17/2021 | $0 |
| | 2022 | 2019 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 000 | 3 | NIH | 11/20/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,274,086 ) |
| | 2021 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R42HL158510 | Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | 000 | 1 | NIH | 5/26/2021 | $299,871 |
| | 2021 | 2021 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44MH119621 | The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND) | 000 | 2 | NIH | 4/23/2021 | $975,197 |
| | 2021 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43AR073565 | The Stem Cell-Derived Muscle Function Assay: A High Throughput Screening Platform Utilizing Kinetic Image Cytometry to Discover Therapeutics for Duchenne Muscular Dystrophy | 000 | 1 | NIH | 8/25/2021 | -$982 |
| | 2021 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R41MH119621 | The Microscopic Imaging of Epigenetic Landscape- NeuroDevelopment (MIEL-ND) assay: a high throughput platform to screen compounds for neurodevelopmental effects | 000 | 1 | NIH | 3/25/2021 | $0 |
| | 2021 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43AG062012 | The Alzheimer's Therapeutics Screening Assay: a high-throughput drug-discovery platform utilizing neurons and microglia derived from human induced pluripotent stem cells and Kinetic Image Cytometry | 000 | 1 | NIH | 8/19/2021 | $0 |
| | 2021 | 2017 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES023521 | Stem cell toxicology assays for cardiac differentiation | 000 | 3 | NIH | 8/14/2021 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $742,257 ) |
| | 2019 | 2019 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 002 | 3 | NIH | 7/24/2019 | $742,257 |
| | 2019 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 000 | 2 | NIH | 3/28/2019 | $0 |
| | 2019 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 001 | 2 | NIH | 3/29/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $2,091,838 ) |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43AR073565 | The Stem Cell-Derived Muscle Function Assay: A High Throughput Screening Platform Utilizing Kinetic Image Cytometry to Discover Therapeutics for Duchenne Muscular Dystrophy | 000 | 1 | NIH | 9/19/2018 | $225,000 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 000 | 2 | NIH | 5/23/2018 | $752,246 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43AG062012 | The Alzheimer's Therapeutics Screening Assay: a high-throughput drug-discovery platform utilizing neurons and microglia derived from human induced pluripotent stem cells and Kinetic Image Cytometry | 000 | 1 | NIH | 9/15/2018 | $301,078 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 002 | 2 | NIH | 9/17/2018 | $513,514 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R41MH119621 | The Microscopic Imaging of Epigenetic Landscape- NeuroDevelopment (MIEL-ND) assay: a high throughput platform to screen compounds for neurodevelopmental effects | 000 | 1 | NIH | 9/8/2018 | $83,634 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R41MH119621 | The Microscopic Imaging of Epigenetic Landscape- NeuroDevelopment (MIEL-ND) assay: a high throughput platform to screen compounds for neurodevelopmental effects | 000 | 1 | NIH | 9/8/2018 | $216,366 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 001 | 2 | NIH | 8/31/2018 | $513,514 |
| | 2018 | 2018 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES026268 | Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons | 002 | 2 | NIH | 9/17/2018 | -$513,514 |
| | 2018 | 2017 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES023521 | Stem cell toxicology assays for cardiac differentiation | 000 | 3 | NIH | 5/18/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $738,406 ) |
| | 2017 | 2017 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R44ES023521 | Stem cell toxicology assays for cardiac differentiation | 000 | 3 | NIH | 2/9/2017 | $738,406 |
| | 2017 | 2015 | VALA SCIENCES INC. | 6370 NANCY RIDGE DR STE 106 | SAN DIEGO | CA | 92121-1320 | SAN DIEGO | USA | R43ES026268 | Assay of chemicals for Parkinson?s toxicity in human iPSC-derived neurons | 000 | 1 | NIH | 2/8/2017 | $0 |
|
|
